ABVX: ABIVAX Kompaniya qiymatining sof foydaga nisbati
IBD terapiyasiga bo'lgan barqaror talab ABIVAX (ABVX) kompaniyasiga ko'p yillik ortiqcha foydalar keltirishni va'da qilmoqda, buni P/E ko'rsatkichi darajasi tasdiqlaydi, bunda joriy holat -15.90 hisoblanadi. Biofarmatsevtika biznesining muvaffaqiyati klinik sinovlar natijalari va tartibga soluvchi organlarning tasdiqlashiga bog'liq. Shu bilan birga, operatsion model uning gumanitar maqomi bilan himoyalangan bo'lib, bu har qanday geosiyosiy risklar va sanksiyalar bosimini minimallashtiradi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261112&filename=GURU_Markets_-_ABVX_-_ABIVAX_-_PE-Multiple "ABVX: Abivax SA Biznesning o‘zini qoplash muddati 21.02.2024 - 12.11.2026 | 👁️GURU.Markets👁️")
ABIVAX (ABVX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati ABIVAX|ABVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati abivax.com|ABVX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Abivax SA|ABVX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Abivax|Tezkor likvidlik koeffitsiyenti abivax.com
- foyda va bozor multiplikatorlari tafsilotlari:
ABVX - Sof foyda|Kutilayotgan foyda ABIVAX|ABVX - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Abivax S.A.|ABVX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Abivax SA|ABVX - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Abivax|ABVX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi abivax.com|ABVX - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi ABIVAX
Kompaniyaning har tomonlama tahlili:Abivax SA ABVX
ABIVAX (ABVX) barqarorligi ichak yallig'lanishi terapiyasi uchun obefeximodning muvaffaqiyatli bozorga chiqarilishiga bog'liq. P/E koeffitsiyentini tahlil qilish orqali investor kelajakdagi daromadlar uchun premiumni aniqlaydi, bunda ko'paytiruvchining o'sishi dori vositasining tijoratlashtirilishiga bo'lgan bozor ishonchini aks ettiradi, haddan tashqari keskin ko'tarilish esa aktiv uchun ortiqcha to'lovni va potentsial investitsiya daromadlarining kamayishini bildiradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ADMA (ADMA Biologics Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori PTGX (Protagonist Therapeutics Inc)|Biznesning o‘zini qoplash muddati Immunovant Therapeutics (IMVT)|KNSA - Narxning foydaga nisbati|grifols.com (GRFS) - Narx-foyda koeffitsiyenti|Adaptive Biotechnologies Corporation (ADPT) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Celldex Therapeutics Inc|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori BioCryst Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|PGEN - P/E multiplikatori|PHAR: P/E multiplikatori|NKTR (nektar.com) - Narxning foydaga nisbati|UPB (Upstream Bio) - P/E multiplikatori|Zenas Bio (ZBIO) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti IMNM (Immunome Corp)|Narxning foydaga nisbati GOSS (Gossamer Bio Corp.)|P/E multiplikatori KALV (KalVista Pharmaceuticals)|P/E multiplikatori septerna.com SEPN|PVLA: Narx-foyda koeffitsiyenti|SVRA (Savara Inc) - Narx-foyda multiplikatori|RIGL: P/E multiplikatori|AnaptysBio Inc. (ANAB) - P/E multiplikatori|ATXS (Astria Therapeutics) - P/E multiplikatori|Narxning foydaga nisbati ENGN|Narx-foyda koeffitsiyenti RAPT (RAPT Therapeutics)|Narxning foydaga nisbati JBIO (aerovatetx.com)|Aclaris - Narx-foyda koeffitsiyenti|KYTX: Narx-foyda multiplikatori|TLSA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CABA|VTYX: P/E multiplikatori|Theratechnologies, Inc. - Kompaniya qiymatining sof foydaga nisbati|AVTX (Avalo Therapeutics Inc.) - P/E multiplikatori|P/E multiplikatori Eledon Pharmaceuticals, Inc|Narxning foydaga nisbati Agenus (AGEN)|CLYM (climbbio.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Zura Bio ZURA|ATYR - Narx-foyda koeffitsiyenti|Adagene Corp - P/E multiplikatori|IMA - P/E multiplikatori|STTK (shattucklabs.com) - Narx-foyda koeffitsiyenti|Equillium - Kompaniya qiymatining sof foydaga nisbati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|Immunic Inc (IMUX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|Narx-foyda koeffitsiyenti inflarx.de IFRX|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET - Narx-foyda koeffitsiyenti|CELU: Narx-foyda koeffitsiyenti|INMB - P/E multiplikatori|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Narx-foyda multiplikatori KZR|SABS (SAB Biotherapeutics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati akaritx.com AKTX|P/E multiplikatori ENLV|P/E multiplikatori q32bio.com (QTTB)|P/E multiplikatori GOVX (GeoVax Labs Inc)|Edesa Biotech Corp - Narxning foydaga nisbati|iBio, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati Carisma Therapeutics CARM|XTLB (XTL Biopharmaceuticals Ltd.) - Narx-foyda koeffitsiyenti|BOLT (Bolt Biotherapeutics, Inc.) - Narxning foydaga nisbati|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|aditxt.com - Narx-foyda multiplikatori|P/E multiplikatori GRI (GRI Bio)|P/E multiplikatori XORTX Therapeutics Inc XRTX|ReShape Lifesciences - P/E multiplikatori|REVB: Narxning foydaga nisbati|INDP (Indaptus Therapeutics) - Narx-foyda koeffitsiyenti|SCNI (scinai.com) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti CALI|Narx-foyda multiplikatori AFMD (Affimed Therapeutics)|Narxning foydaga nisbati Allakos Inc. (ALLK)|HOOK: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori IGMS (IGM Biosciences)|Kompaniya qiymatining sof foydaga nisbati ITOS|Ocean Biomedical - P/E multiplikatori|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
